Oyama, Japan

Yasuhiko Sakoe

This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuhiko Sakoe. Retrieved from https://idiyas.com/inventor/yasuhiko-sakoe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuhiko Sakoe: Innovator in Pharmaceutical Chemistry

Introduction

Yasuhiko Sakoe is a notable inventor based in Oyama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on cyclic aminophenylacetic acid derivatives.

Latest Patents

Sakoe holds a patent for cyclic aminophenylacetic acid derivatives, which includes a process for preparing these compounds. This patent showcases his expertise and dedication to advancing pharmaceutical science.

Career Highlights

Sakoe is associated with Kyorin Pharmaceutical Co., Ltd., where he has been instrumental in developing new pharmaceutical products. His work has contributed to the company's reputation for innovation in the healthcare sector.

Collaborations

Throughout his career, Sakoe has collaborated with esteemed colleagues such as Yasushi Kohno and Koji Saito. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Yasuhiko Sakoe's contributions to pharmaceutical chemistry and his innovative patents reflect his commitment to advancing medical science. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…